Inhibition of Matrix Metalloproteinases as a Feasible Therapeutic Target in Rheumatoid Arthritis

E-ISSN： 1875-6360|4|4|288-297

ISSN： 1573-3971

Source： Current Rheumatology Reviews, Vol.4, Iss.4, 2008-11, pp. : 288-297

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Matrix Metalloproteinases in Vascular Disease - A Potential Therapeutic Target?

Current Vascular Pharmacology, Vol. 8, Iss. 1, 2010-01 ,pp. : 75-85

Bentham Science Publishers

Access to resources Recommend Favorite

The Axis of Thrombospondin-1, Transforming Growth Factor Beta and Connective Tissue Growth Factor: An Emerging Therapeutic Target in Rheumatoid Arthritis

Current Vascular Pharmacology, Vol. 8, Iss. 3, 2010-05 ,pp. : 338-343

Bentham Science Publishers

Access to resources Recommend Favorite

Is the Vasculature a Potential Therapeutic Target in Arthritis?

Current Rheumatology Reviews, Vol. 2, Iss. 2, 2006-05 ,pp. : 151-158

Bentham Science Publishers

Access to resources Recommend Favorite

The Osteoclast as a New Target in the Treatment of Rheumatoid Arthritis: A Role for the Bisphosphonates?

Current Rheumatology Reviews, Vol. 1, Iss. 2, 2005-01 ,pp. : 125-129

Bentham Science Publishers

Access to resources Recommend Favorite

Impact of TNF inhibition on insulin resistance and lipids levels in patients with rheumatoid arthritis

By Tam Lai-Shan Tomlinson Brian Chu Tanya Li Tena Li Edmund

Clinical Rheumatology, Vol. 26, Iss. 9, 2007-09 ,pp. : 1495-1498

Springer Publishing Company

Access to resources Recommend Favorite